Medication info
Tenireum Sustained-release Tablets 10/750 mg

Tenireum Sustained-release Tablets 10/750 mg

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›750mg / 1 tabletTeneligliptin Hydrochloride Hydrate›12.98mg / 1 tablet
Manufacturer / importer
Kyeongdong Pharmaceutical Co., Ltd.
Appearance
Yellow, double-convex, oval sustained-release film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202202806 · Approved 2022.07.06 · Insurance code 648104800

Summary

Main use
Improvement of glycemic control in type 2 diabetes
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment with this medicine may be started at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other antihyperglycemic agents. Because such a switch may cause changes in glycemic control, any changes in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain the extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
Kyeongdong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes

View approved original text

This medication is used to assist patients with type 2 diabetes in controlling their blood sugar levels. The combined action of teneligliptin and metformin helps in effectively managing blood sugar through meal planning and exercise. It helps prevent elevated blood sugar levels, maintaining health. By taking it consistently, blood sugar control can improve, facilitating better diabetes management.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment with this medicine may be started at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other antihyperglycemic agents. Because such a switch may cause changes in glycemic control, any changes in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain the extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This medication helps control blood sugar levels and is used for diabetic patients. However, it may rarely cause a serious condition known as lactic acidosis, so caution is necessary. Lactic acidosis is a dangerous condition that occurs when there is excessive buildup of lactic acid in the body; if symptoms occur, medical attention should be sought immediately. Additionally, when used with other diabetes medications, hypoglycemia may occur, so blood sugar levels should be monitored closely. Patients with moderately decreased or severely impaired kidney or heart function should not use this medication. Especially if kidney function tests reveal values below certain thresholds, use should be discontinued, and the medication should be stopped immediately in suspected cases of kidney dysfunction. Before undergoing tests using radiological iodinated contrast agents, this medication should be discontinued at least 48 hours prior, and re-initiation of use should occur only after confirming normal kidney function post-examination. Women who are pregnant or may become pregnant should preferably avoid this medication. If symptoms such as gastrointestinal disturbances, severe abdominal pain, shortness of breath, skin rash, blisters, etc., occur during use, consult a physician immediately. This medication is also not recommended for patients with poor liver function, and excessive alcohol consumption should be avoided. Elderly patients may experience decreased kidney function; thus, regular kidney function tests are recommended, and dosage adjustments may be needed. Additionally, during administration of this medication, vitamin B12 levels may decrease, so regular blood tests are recommended. In case of overdose, medical help should be sought immediately, as this medication can be removed through hemodialysis. Finally, safety and efficacy have not been established for children, so it is not used in pediatric patients.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • cough
  • respiratory distress
  • fever
Show 157 more
  • abnormal lung sounds
  • bullous pemphigoid
  • blisters
  • ulcers
  • acute pancreatitis
  • dizziness
  • abdominal bloating
  • abdominal discomfort
  • nausea
  • abdominal pain
  • distention
  • stomatitis
  • gastric polyps
  • colonic polyps
  • duodenal ulcer
  • gastroesophageal reflux disease
  • diarrhea
  • loss of appetite
  • amylase elevation
  • lipase elevation
  • AST elevation
  • ALT elevation
  • GGT elevation
  • ALP elevation
  • proteinuria
  • ketonuria
  • latent hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • CK elevation
  • elevated serum potassium levels
  • malaise
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • hypoglycemia
  • tremors
  • headache
  • weakness
  • hunger
  • fatigue
  • facial swelling
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • shingles
  • rhinitis
  • cold sweat
  • diabetic retinopathy
  • visual impairment
  • cough
  • pulmonary congestion
  • respiratory distress
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • diarrhea
  • chronic gastritis
  • irritable bowel syndrome
  • fatigue
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • decreased neutrophil count
  • abnormal blood sugar
  • increased blood sugar
  • increased blood pressure
  • hepatic encephalopathy
  • lumbar spinal canal stenosis
  • intervertebral disc protrusion
  • intervertebral disc disorder
  • spinal ligament ossification
  • foraminal stenosis
  • rotator cuff syndrome
  • bladder tumor
  • ureterolithiasis
  • urinary stones
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyps
  • gastritis
  • bile duct obstruction
  • chronic cholecystitis
  • soft tissue infection
  • pneumonia
  • cataract
  • depression
  • iliac artery stenosis
  • vertigo
  • benign prostatic hyperplasia
  • knee surgery
  • dizziness
  • diabetic neuropathy
  • sensory disturbance
  • muscle weakness
  • back pain
  • limb pain
  • tendonitis
  • cervical pain
  • bone pain
  • osteoarthritis
  • osteoporosis
  • muscle spasms
  • foot deformities
  • hypertrophic osteoarthropathy
  • bursitis
  • spinal osteoarthritis
  • postmenopausal osteoporosis
  • chronic sinusitis
  • folliculitis
  • cystitis
  • urinary tract infection
  • pharyngitis
  • streptococcal infection
  • athlete's foot
  • subcutaneous abscess
  • gastroenteritis
  • vomiting
  • abdominal pain
  • gastrointestinal motility disorder
  • enteritis
  • toothache
  • anal discomfort
  • acquired mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • essential hypertension
  • orthostatic hypotension
  • white coat hypertension
  • bleeding
  • abnormal sputum
  • toxic hepatitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid injury
  • ligament sprain
  • lip injury
  • contusion
  • hives
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • angina pectoris
  • ear pain
  • iron deficiency anemia
  • food allergy
  • pressure ulcer
  • ovarian cyst
  • vulvar pruritus
  • menopausal symptoms

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to store the medication at room temperature between 1°C and 30°C, avoiding extremely hot or cold places.

Appearance and packaging

Appearance

Yellow, double-convex, oval sustained-release film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.